142 related articles for article (PubMed ID: 29941168)
21. Pathophysiology of placental-derived fetal growth restriction.
Burton GJ; Jauniaux E
Am J Obstet Gynecol; 2018 Feb; 218(2S):S745-S761. PubMed ID: 29422210
[TBL] [Abstract][Full Text] [Related]
22. The effect of pre-existing maternal obesity and diabetes on placental mitochondrial content and electron transport chain activity.
Hastie R; Lappas M
Placenta; 2014 Sep; 35(9):673-83. PubMed ID: 25002362
[TBL] [Abstract][Full Text] [Related]
23. Placental mitochondrial DNA mutations and copy numbers in intrauterine growth restricted (IUGR) pregnancy.
Naha R; Anees A; Chakrabarty S; Naik PS; Pandove M; Pandey D; Satyamoorthy K
Mitochondrion; 2020 Nov; 55():85-94. PubMed ID: 32861875
[TBL] [Abstract][Full Text] [Related]
24. [Relationships between concentrations of free fatty acid in serum and oxidative-damage levels in placental mitochondria and preeclampsia].
Yan JY; Xu X
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):412-7. PubMed ID: 22932105
[TBL] [Abstract][Full Text] [Related]
25. Placental respiratory chain complex activities in high risk pregnancies.
Beyramzadeh M; Dikmen ZG; Erturk NK; Tuncer ZS; Akbiyik F
J Matern Fetal Neonatal Med; 2017 Dec; 30(24):2911-2917. PubMed ID: 27915495
[TBL] [Abstract][Full Text] [Related]
26. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
[TBL] [Abstract][Full Text] [Related]
27. Involvement of estrogen-related receptor-γ and mitochondrial content in intrauterine growth restriction and preeclampsia.
Poidatz D; Dos Santos E; Duval F; Moindjie H; Serazin V; Vialard F; De Mazancourt P; Dieudonné MN
Fertil Steril; 2015 Aug; 104(2):483-90. PubMed ID: 26051094
[TBL] [Abstract][Full Text] [Related]
28. The role of homeobox genes in the development of placental insufficiency.
Murthi P; Kalionis B; Rajaraman G; Keogh RJ; Da Silva Costa F
Fetal Diagn Ther; 2012; 32(4):225-30. PubMed ID: 22906990
[TBL] [Abstract][Full Text] [Related]
29. Maternal calorie restriction modulates placental mitochondrial biogenesis and bioenergetic efficiency: putative involvement in fetoplacental growth defects in rats.
Mayeur S; Lancel S; Theys N; Lukaszewski MA; Duban-Deweer S; Bastide B; Hachani J; Cecchelli R; Breton C; Gabory A; Storme L; Reusens B; Junien C; Vieau D; Lesage J
Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E14-22. PubMed ID: 23092912
[TBL] [Abstract][Full Text] [Related]
30. Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction.
Hannan NJ; Beard S; Binder NK; Onda K; Kaitu'u-Lino TJ; Chen Q; Tuohey L; De Silva M; Tong S
Placenta; 2017 Mar; 51():1-9. PubMed ID: 28292463
[TBL] [Abstract][Full Text] [Related]
31. Mining DNA methylation alterations towards a classification of placental pathologies.
Wilson SL; Leavey K; Cox BJ; Robinson WP
Hum Mol Genet; 2018 Jan; 27(1):135-146. PubMed ID: 29092053
[TBL] [Abstract][Full Text] [Related]
32. Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.
Weber M; Göhner C; San Martin S; Vattai A; Hutter S; Parraga M; Jeschke U; Schleussner E; Markert UR; Fitzgerald JS
Cell Adh Migr; 2016 Mar; 10(1-2):56-65. PubMed ID: 26914354
[TBL] [Abstract][Full Text] [Related]
33. Placental vessel morphometry in growth retardation and increased resistance of the umbilical artery Doppler flow.
Mitra SC; Seshan SV; Riachi LE
J Matern Fetal Med; 2000; 9(5):282-6. PubMed ID: 11132583
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway.
Ain R; Canham LN; Soares MJ
J Endocrinol; 2005 May; 185(2):253-63. PubMed ID: 15845918
[TBL] [Abstract][Full Text] [Related]
35. Caspase dependent and independent mechanisms of apoptosis across gestation in a sheep model of placental insufficiency and intrauterine growth restriction.
Monson T; Wright T; Galan HL; Reynolds PR; Arroyo JA
Apoptosis; 2017 May; 22(5):710-718. PubMed ID: 28083721
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial DNA in placenta: associations with fetal growth and superoxide dismutase activity.
Díaz M; Aragonés G; Sánchez-Infantes D; Bassols J; Pérez-Cruz M; de Zegher F; Lopez-Bermejo A; Ibáñez L
Horm Res Paediatr; 2014; 82(5):303-9. PubMed ID: 25247554
[TBL] [Abstract][Full Text] [Related]
37. Utility of DNA methylation to assess placental health.
Wilson SL; Robinson WP
Placenta; 2018 Apr; 64 Suppl 1():S23-S28. PubMed ID: 29273273
[TBL] [Abstract][Full Text] [Related]
38. Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia.
Kappou D; Sifakis S; Androutsopoulos V; Konstantinidou A; Spandidos DA; Papantoniou N
Placenta; 2014 Sep; 35(9):718-23. PubMed ID: 25047691
[TBL] [Abstract][Full Text] [Related]
39. Altered miRNA-4321 expression in maternal and foetal placenta of intrauterine growth restricted bovine foetuses.
Rutkowska K; Stachowiak M; Oprzadek J; Bauersachs S; Flisikowski K
Placenta; 2018 Oct; 70():50-52. PubMed ID: 30316327
[TBL] [Abstract][Full Text] [Related]
40. [The placenta in the fetal growth retardation syndrome (SFD)].
De Virgiliis G; Bianco V; Cima P; Crippa A; Remotti G
Ann Ostet Ginecol Med Perinat; 1978; 99(2):75-94. PubMed ID: 655548
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
